Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ROBERT M. SILVER who wrote (1020)	7/16/1998 6:30:00 AM
From: Tony van Werkhooven	Read Replies (1) of 1491

Robert- I am a little confused by your post.. Any payments (before holdback) from BOL in the second quarter should be reported as revenue. I am assuming that the 5 million advance from BOL was in fact booked as a loan - shown as "advances against future sales" in the 10Q. Hence, the holdback (i.e. repayment ) will not impact the income statement, but will be reflected in the cash flow analysis as a "use of cash". Please let me know if I misread your post. Tony

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next